First fully integrated spatial multiomic assay from 10x Genomics (TXG) brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif ...

In the September 9 cover article of Cancer Cell, researchers integrated 10x single cell and spatial technologies to identify a mechanism of glioblastoma recurrence in mice and develop a promising ...

10x Genomics, Inc., l'Institut Garvan de Recherche Médicale en Australie et l'Université de Tokyo au Japon ont annoncé une initiative commune visant à créer un atlas spatial exhaustif des cancers. Le ...

PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc.(Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial ...

On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer samples into high-resolution, multimodal datasets, backed by £18.9 million in ...

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region ASTRA will bring together molecular and spatial data ...

10x Genomics, together with the Garvan Institute of Medical Research and the University of Tokyo, recently announced the formation of the Asia-Pacific Spatial Translational Research Alliance (ASTRA) ...